×
ADVERTISEMENT

DECEMBER 8, 2020

Major Milestones Loom in COVID-19 Vaccine Approval Process

By Gina Shaw
The next two weeks promise to be perhaps the most eventful in the history of the development of vaccines against the virus that causes COVID-19. The first milestone: the FDA released phase 3 trial safety data on Pfizer’s vaccine candidate BNT162b2, developed with Germany’s BioNTech.

“All previous public knowledge about safety and efficacy of this vaccine has been based on the phase 1 to 2 trials and on press releases,” said Litjen (LJ) Tan, MS, PhD,